EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss

Hui Wang, Kimon Divaris, Bohu Pan, Xiaofei Li, Jong-Hyung Lim, Gundappa Saha, Marko Barovic, Danai Giannakou, Jonathan M Korostoff, Yu Bing, Souvik Sen, Kevin Moss und 8 weitere

Cell · 2024-07 · 187 (14) · 3690-3711.e19

DOI: 10.1016/j.cell.2024.05.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2024-07. Verfasst von Hui Wang und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic and Translational Sciences, Laboratory of Innate Immunity and Inflammation, Penn Dental Medicine, University of Pennsylvania, Phi…. Hauptthemen laut MEDLINE: DNA Methyltransferase 3A, DNA (Cytosine-5-)-Methyltransferases, Clonal Hematopoiesis, Periodontitis. Die Arbeit wurde bisher 131-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIEHS NIH HHS, NIDCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clonal hematopoiesis of indeterminate potential (CHIP) arises from aging-associated acquired mutations in hematopoietic progenitors, which display clonal expansion and produce phenotypically altered leukocytes. We associated CHIP-DNMT3A mutations with a higher prevalence of periodontitis and gingival inflammation among 4,946 community-dwelling adults. To model DNMT3A-driven CHIP, we used mice with the heterozygous loss-of-function mutation R878H, equivalent to the human hotspot mutation R882H. Partial transplantation with Dnmt3aR878H/+ bone marrow (BM) cells resulted in clonal expansion of mutant cells into both myeloid and lymphoid lineages and an elevated abundance of osteoclast precursors in the BM and osteoclastogenic macrophages in the periphery. DNMT3A-driven clonal hematopoiesis in recipient mice promoted naturally occurring periodontitis and aggravated experimentally induced periodontitis and arthritis, associated with enhanced osteoclastogenesis, IL-17-dependent inflammation and neutrophil responses, and impaired regulatory T cell immunosuppressive activity. DNMT3A-driven clonal hematopoiesis and, subsequently, periodontitis were suppressed by rapamycin treatment. DNMT3A-driven CHIP represents a treatable state of maladaptive hematopoiesis promoting inflammatory bone loss.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA Methyltransferase 3ADNA (Cytosine-5-)-MethyltransferasesClonal HematopoiesisPeriodontitisAnimalsMiceHumansMutationMaleFemaleInflammationOsteoclastsMice, Inbred C57BLAdultInterleukin-17T-Lymphocytes, RegulatoryHematopoiesisOsteogenesisHematopoietic Stem CellsBone ResorptionMiddle Aged

Stichwörter der Autor:innen

DNMT3AT cellsarthritisbone marrowclonal hematopoiesis of indeterminate potentialhematopoietic stem and progenitor cellsinflammationneutrophilsosteoclastogenesisperiodontitis

Substanzen

DNA Methyltransferase 3ADNA (Cytosine-5-)-MethyltransferasesDnmt3a protein, mouseDNMT3A protein, humanInterleukin-17

Autor:innen und Institutionen

  • Department of Basic and Translational Sciences, Laboratory of Innate Immunity and Inflammation, Penn Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Division of Pediatric and Public Health, Adams School of Dentistry, University of North Carolina, Chapel Hill, Chapel Hill, NC 27599, USA; Department of Epidemiology, Gillings School of Global Public Health, University…
  • Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR 72079, USA.
  • Department of Basic and Translational Sciences, Laboratory of Innate Immunity and Inflammation, Penn Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Shanghai Jiao Tong University, School of Lif…
  • Institute for Clinical Chemistry and Laboratory Medicine, University Hospital, Technische Universität Dresden, 01307 Dresden, Germany.
  • Department of Periodontics, Laboratory of Innate Immunity and Inflammation, Penn Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Förderung

  • NHLBI NIH HHS
  • NIEHS NIH HHS
  • NIDCR NIH HHS
  • NCRR NIH HHS
  • NHGRI NIH HHS
  • Netherlands Organisation for Scientific Research
  • Deutsche Forschungsgemeinschaft
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Wang, H., Divaris, K., Pan, B., Li, X., Lim, J. H., Saha, G., Barovic, M., Giannakou, D., Korostoff, J. M., Bing, Y., Sen, S., Moss, K., Wu, D., Beck, J. D., Ballantyne, C. M., Natarajan, P., North, K. E., Netea, M. G., Chavakis, T., & Hajishengallis, G. (2024). Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss. Cell, 187(14), 3690-3711.e19. https://doi.org/10.1016/j.cell.2024.05.003

Vancouver

Wang H, Divaris K, Pan B, Li X, Lim JH, Saha G, et al. Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss. Cell. 2024;187(14):3690-3711.e19. doi:10.1016/j.cell.2024.05.003

BibTeX
@article{Wang2024,
  author = {Wang, Hui and Divaris, Kimon and Pan, Bohu and Li, Xiaofei and Lim, Jong-Hyung and Saha, Gundappa and Barovic, Marko and Giannakou, Danai and Korostoff, Jonathan M and Bing, Yu and Sen, Souvik and Moss, Kevin and Wu, Di and Beck, James D and Ballantyne, Christie M and Natarajan, Pradeep and North, Kari E and Netea, Mihai G and Chavakis, Triantafyllos and Hajishengallis, George},
  title = {Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss},
  journal = {Cell},
  year = {2024},
  volume = {187},
  number = {14},
  pages = {3690--3711.e19},
  doi = {10.1016/j.cell.2024.05.003}
}
Kostenlos starten →